Join the HIV Infection group to help and get support from people like you.
HIV Infection News
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV
FOSTER CITY, Calif.--(BUSINESS WIRE) April 26, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data...
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 – Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research published online April 23...
Pandemic Reignited Debate Regarding Physician's Obligation to Treat
MONDAY, April 29, 2024 – There was a surge in ethics literature during COVID-19 advocating for the ethical acceptability of physicians refusing to treat, according to a study published online April...
Clients Got HIV Through 'Vampire Facial' Microneedling Treatments
FRIDAY, April 26, 2024 (HealthDay) – Between 2018 and the spring of 2023, a cluster of clients who had gotten 'vampire facial' microneedling skin treatments at a New Mexico spa were diagnosed with...
Coronary Artery Vessel Wall Thickness Increased for People Living With HIV
TUESDAY, April 16, 2024 – Asymptomatic people living with HIV (PLWH) with a low risk for cardiovascular disease have increased coronary artery vessel wall thickness (VWT), according to a study...
FDA Approves Dovato for Teens Living With HIV
WEDNESDAY, April 10, 2024 – The U.S. Food and Drug Administration has approved Dovato (dolutegravir/lamivudine) for adolescents living with HIV. The approval is for the treatment of HIV-1 infection...
ViiV Healthcare Announces U.S. FDA Approval of Dovato (dolutegravir/lamivudine) for Adolescents Living with HIV
Durham, NC, April 8, 2024 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the U.S. Food and Drug Administration (...
Even HIV Patients Without Symptoms May Have Underlying Heart Trouble
FRIDAY, April 5, 2024 – People with HIV could have an increased risk of heart disease even if they aren’t suffering any symptoms related to their infection, a new study finds. Middle-aged people l...
GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
MONDAY, March 18, 2024 – For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic...
High Rate of PrEP Discontinuation Seen for Sexual Gender-Minority People
THURSDAY, March 14, 2024 – Among sexual and gender-minority people who initiate preexposure prophylaxis (PrEP) for HIV, the annual rate of discontinuation is between 35 and 40 percent, according to...
Dapivirine Vaginal Ring Safe, Effective at Preventing HIV During Pregnancy
THURSDAY, March 14, 2024 – Adverse pregnancy outcomes related to use of the dapivirine vaginal ring (DVR) or daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) during the second...
Children Can Remain HIV-Free After Pause in Antiretroviral Therapy
WEDNESDAY, March 13, 2024 – Very early treatment of in utero HIV-1 can result in antiretroviral therapy (ART)-free remission for ≥48 weeks, according to a study presented at the annual Conference on ...
Long-Acting Injectable ART Superior to Standard Care for Poorly Adherent People With HIV
TUESDAY, March 12, 2024 – For people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is...
Nurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIV
MONDAY, March 11, 2024 – Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving antiretroviral therapy, according to a study published online March 5 in JAMA ...
Early Treatment Can Push HIV Into Remission in Kids: Study
FRIDAY, March 8, 2024 – Ever since one child, dubbed the 'Mississippi baby,' went into drug-free remission of HIV in 2013, experts have wondered if giving treatment within hours of birth might do...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq